The S&P Kensho Genetic Engineering Index is designed to measure the performance of companies involved in the genetic engineering industry, including those that provide tools to allow other companies to more efficiently execute their own research.

A subsector index within the S&P Kensho New Economy Index Series, the S&P Kensho Genetic Engineering Index intends to represent companies that are focused on genetic engineering, or the use of biotechnology to alter the genes of living cells in animals, plants, and people. Genetic engineering offers possibilities for breakthrough medical therapies and diagnostics, as well as producing more nutritious and resilient crops and livestock. The economic influence of genetic engineering, both directly and indirectly, will also be significant once the products move into the mainstream.